• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶D参与阿尔茨海默病β-淀粉样蛋白的清除过程。

Cathepsin D is involved in the clearance of Alzheimer's beta-amyloid protein.

作者信息

Hamazaki H

机构信息

Department of Biology, Kitasato University School of Medicine, Kanagawa, Japan.

出版信息

FEBS Lett. 1996 Nov 4;396(2-3):139-42. doi: 10.1016/0014-5793(96)01087-3.

DOI:10.1016/0014-5793(96)01087-3
PMID:8914975
Abstract

The cerebral deposition of 39-42 residue amyloid beta-protein (Abeta) is a histopathological characteristic of Alzheimer's disease. The present study is aimed at finding proteinases responsible for the intracellular clearance of Abeta. The Abeta-degrading proteinase was purified from rat brain. Amino-terminal sequence analysis indicated the Abeta-degrading proteinase was cathepsin D. Purified cathepsin D hydrolyzed Abeta between Phe19 and Phe20. Cathepsin D is likely to be involved in the intracellular clearance of aggregatable Abeta, since Abeta fragments with Phe20 at the amino-terminus have been reported to be secreted from several lines of cultured cells.

摘要

由39 - 42个氨基酸残基组成的β-淀粉样蛋白(Aβ)在大脑中的沉积是阿尔茨海默病的组织病理学特征。本研究旨在寻找负责细胞内清除Aβ的蛋白酶。从大鼠脑中纯化出了降解Aβ的蛋白酶。氨基末端序列分析表明,降解Aβ的蛋白酶是组织蛋白酶D。纯化的组织蛋白酶D在苯丙氨酸19和苯丙氨酸20之间水解Aβ。组织蛋白酶D可能参与了可聚集Aβ的细胞内清除,因为据报道,氨基末端带有苯丙氨酸20的Aβ片段可从多种培养细胞系中分泌出来。

相似文献

1
Cathepsin D is involved in the clearance of Alzheimer's beta-amyloid protein.组织蛋白酶D参与阿尔茨海默病β-淀粉样蛋白的清除过程。
FEBS Lett. 1996 Nov 4;396(2-3):139-42. doi: 10.1016/0014-5793(96)01087-3.
2
A beta-amyloid peptide variant related with familial Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis is poorly eliminated by cathepsin D.一种与家族性阿尔茨海默病和淀粉样变性遗传性脑出血相关的β-淀粉样肽变体被组织蛋白酶D清除的效率很低。
FEBS Lett. 1996 Nov 18;397(2-3):313-5. doi: 10.1016/s0014-5793(96)01202-1.
3
Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D.组织蛋白酶D对阿尔茨海默病β淀粉样蛋白氨基端和羧基端的切割
J Biol Chem. 1994 Jul 15;269(28):18422-8.
4
Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease.单核细胞中组织蛋白酶D的表达降低与阿尔茨海默病中淀粉样β蛋白的降解缺陷有关。
J Alzheimers Dis. 2014;42(2):511-20. doi: 10.3233/JAD-132192.
5
Degradation of Alzheimer's beta-amyloid protein by human cathepsin D.人组织蛋白酶D对阿尔茨海默病β-淀粉样蛋白的降解作用
Neuroreport. 1996 Sep 2;7(13):2163-6. doi: 10.1097/00001756-199609020-00021.
6
In vitro processing of amyloid precursor protein by cathepsin D.
Int J Biochem Cell Biol. 1999 Nov;31(11):1327-37. doi: 10.1016/s1357-2725(99)00053-9.
7
Cathepsin D displays in vitro beta-secretase-like specificity.组织蛋白酶D在体外表现出β-分泌酶样特异性。
Brain Res. 1997 Mar 7;750(1-2):11-9. doi: 10.1016/s0006-8993(96)01330-3.
8
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.ADAM30 通过激活组织蛋白酶 D 下调阿尔茨海默病中与 APP 相关的缺陷。
EBioMedicine. 2016 Jul;9:278-292. doi: 10.1016/j.ebiom.2016.06.002. Epub 2016 Jun 2.
9
Cathepsin D from Alzheimer's-diseased and normal brains.来自阿尔茨海默病患者大脑和正常大脑的组织蛋白酶D
Exp Neurol. 1995 Jun;133(2):105-12. doi: 10.1006/exnr.1995.1013.
10
Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation.组织蛋白酶D对β-淀粉样前体蛋白的加工过程会因一种家族性阿尔茨海默病突变而增强。
Eur J Biochem. 1994 Sep 1;224(2):265-71. doi: 10.1111/j.1432-1033.1994.00265.x.

引用本文的文献

1
The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia.阿尔茨海默病基因SORL1调节人类小胶质细胞中的溶酶体功能。
Glia. 2025 Jul;73(7):1329-1348. doi: 10.1002/glia.70009. Epub 2025 Apr 4.
2
Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer's disease.阿尔茨海默病中的自噬-溶酶体途径损伤与组织蛋白酶失调
Front Mol Biosci. 2024 Oct 31;11:1490275. doi: 10.3389/fmolb.2024.1490275. eCollection 2024.
3
Integrated multimodal cell atlas of Alzheimer's disease.阿尔茨海默病的综合多模态细胞图谱。
Nat Neurosci. 2024 Dec;27(12):2366-2383. doi: 10.1038/s41593-024-01774-5. Epub 2024 Oct 14.
4
The Alzheimer's disease gene regulates lysosome function in human microglia.阿尔茨海默病基因调节人类小胶质细胞中的溶酶体功能。
bioRxiv. 2025 Jan 7:2024.06.25.600648. doi: 10.1101/2024.06.25.600648.
5
Involvement of Endolysosomes and Aurora Kinase A in the Regulation of Amyloid β Protein Levels in Neurons.内溶酶体和极光激酶 A 参与调节神经元中的淀粉样 β 蛋白水平。
Int J Mol Sci. 2024 Jun 4;25(11):6200. doi: 10.3390/ijms25116200.
6
Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.遗传缺失组织蛋白酶 D 引发显著的 tau 病和细胞内 β-淀粉样蛋白积累:对阿尔茨海默病发病机制的影响。
Alzheimers Res Ther. 2024 Apr 4;16(1):70. doi: 10.1186/s13195-024-01443-6.
7
Poloxamer-188 Exacerbates Brain Amyloidosis, Presynaptic Dystrophies, and Pathogenic Microglial Activation in 5XFAD Mice.泊洛沙姆 188 加剧 5XFAD 小鼠脑淀粉样变性、突触前营养不良和致病性小胶质细胞激活。
Curr Alzheimer Res. 2022;19(4):317-329. doi: 10.2174/1567205019666220509143823.
8
Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.溶酶体肽酶——在癌症进展和神经退行性变中的有趣作用。
FEBS Open Bio. 2022 Apr;12(4):708-738. doi: 10.1002/2211-5463.13372. Epub 2022 Feb 3.
9
Proteolytic α-Synuclein Cleavage in Health and Disease.健康与疾病中的α-突触核蛋白蛋白水解。
Int J Mol Sci. 2021 May 21;22(11):5450. doi: 10.3390/ijms22115450.
10
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer's disease.血单核细胞对淀粉样β的摄取随年龄增长和阿尔茨海默病而减少。
Transl Psychiatry. 2020 Dec 8;10(1):423. doi: 10.1038/s41398-020-01113-9.